effect overlay
activetrials
Stroke
Stroke
LIBREXIA

A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
 

HREC: 2023.046
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Nicola Parsons
Funding: Commercial
Stroke
Stroke
SICARIO

Expanding Stroke therapy access, Stroke in patients with Large ishemic core
 

HREC: 2022.322
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
CASPER

Colchicine After Stroke to Prevent Event Recurrence (CASPER)
 

HREC: 2022.202
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Non-Commercial
Stroke
Stroke
EXTEND-IA Dnase

Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke
 

HREC: 2021.316
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Amy McDonald
Funding: Non-Commercial
Stroke
Stroke
Validation of Intracranial Atherosclerosis Model

Clinical and Imaging Validation of CT Angiogram/Perfusion-Based Computational Fluid Dynamics Modelling in Intracranial Atherosclerosis
 

HREC: 2021.294
Principal Investigator: Dr Davor Pavlin-Premrl
Coordinator contact:
Funding: Non-Commercial